Tove Lekva

2.8k total citations
78 papers, 1.8k citations indexed

About

Tove Lekva is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Tove Lekva has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Obstetrics and Gynecology, 26 papers in Endocrinology, Diabetes and Metabolism and 21 papers in Molecular Biology. Recurrent topics in Tove Lekva's work include Pregnancy and preeclampsia studies (22 papers), Pituitary Gland Disorders and Treatments (17 papers) and Gestational Diabetes Research and Management (17 papers). Tove Lekva is often cited by papers focused on Pregnancy and preeclampsia studies (22 papers), Pituitary Gland Disorders and Treatments (17 papers) and Gestational Diabetes Research and Management (17 papers). Tove Lekva collaborates with scholars based in Norway, United States and Sweden. Tove Lekva's co-authors include Thor Ueland, Jens Bollerslev, Pål Aukrust, Tore Henriksen, Pål Aukrust, Jens Bollerslev, Errol R. Norwitz, Jens Petter Berg, Olivera Casar‐Borota and Stine Lyngvi Fougner and has published in prestigious journals such as PLoS ONE, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Tove Lekva

76 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tove Lekva Norway 25 476 470 441 325 305 78 1.8k
Jacques Beltrand France 25 355 0.7× 867 1.8× 247 0.6× 544 1.7× 566 1.9× 81 2.1k
Walter Krugluger Austria 23 467 1.0× 117 0.2× 228 0.5× 143 0.4× 125 0.4× 87 1.9k
Valorie L. Chiasson United States 23 275 0.6× 146 0.3× 543 1.2× 290 0.9× 191 0.6× 31 1.7k
Paolo Mannella Italy 23 381 0.8× 619 1.3× 179 0.4× 79 0.2× 360 1.2× 120 2.0k
Kambiz Zandi‐Nejad United States 22 600 1.3× 111 0.2× 232 0.5× 250 0.8× 338 1.1× 40 1.8k
Sirkka-Liisa Karonen Finland 24 394 0.8× 747 1.6× 103 0.2× 143 0.4× 290 1.0× 44 2.0k
Erik Van Herck Belgium 22 500 1.1× 654 1.4× 277 0.6× 417 1.3× 148 0.5× 40 2.0k
Kálmán Kovács Hungary 24 344 0.7× 470 1.0× 169 0.4× 93 0.3× 209 0.7× 107 1.5k
Kathleen Laborde France 25 590 1.2× 868 1.8× 60 0.1× 203 0.6× 416 1.4× 55 1.8k
Ernst Beinder Germany 29 322 0.7× 109 0.2× 532 1.2× 732 2.3× 327 1.1× 87 1.8k

Countries citing papers authored by Tove Lekva

Since Specialization
Citations

This map shows the geographic impact of Tove Lekva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tove Lekva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tove Lekva more than expected).

Fields of papers citing papers by Tove Lekva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tove Lekva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tove Lekva. The network helps show where Tove Lekva may publish in the future.

Co-authorship network of co-authors of Tove Lekva

This figure shows the co-authorship network connecting the top 25 collaborators of Tove Lekva. A scholar is included among the top collaborators of Tove Lekva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tove Lekva. Tove Lekva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Godang, Kristin, Tove Lekva, Thor Ueland, et al.. (2024). Long-term depot specific changes in adipose tissue after treatment of acromegaly. European Journal of Endocrinology. 190(3). K37–K42. 2 indexed citations
2.
Nyman, Tuula A., Arvind Y. M. Sundaram, Daniel Dahlberg, et al.. (2024). PCSK1N as a Tumor Size Marker and an ER Stress Response Protein in Corticotroph Pituitary Adenomas. The Journal of Clinical Endocrinology & Metabolism. 110(4). 1065–1075. 1 indexed citations
3.
Steen, Vidar M., Ole A. Andreassen, Nils Eiel Steen, et al.. (2024). Cellular adhesion molecules in drug-naïve and previously medicated patients with schizophrenia-spectrum disorders. Schizophrenia Research. 267. 223–229. 1 indexed citations
4.
Christensen, Jacob J., Nina Gunnes, Kirsten B. Holven, et al.. (2023). Metabolic profiling of pregnancies complicated by preeclampsia: A longitudinal study. Acta Obstetricia Et Gynecologica Scandinavica. 102(3). 334–343. 12 indexed citations
5.
Heck, Ansgar, Kristin Godang, Tove Lekva, et al.. (2023). Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk?. JBMR Plus. 7(10). e10787–e10787. 4 indexed citations
6.
Roland, Marie Cecilie Paasche, Manuela Zucknick, Trine M. Reine, et al.. (2022). Maternal body mass index and placental weight: a role for fetal insulin, maternal insulin and leptin. Journal of Endocrinological Investigation. 45(11). 2105–2121. 8 indexed citations
7.
Ueland, Thor, Kari Otterdal, Tove Lekva, et al.. (2021). Secreted Wnt antagonists in scrub typhus. PLoS neglected tropical diseases. 15(4). e0009185–e0009185. 4 indexed citations
8.
Lekva, Tove, Daniel Pitz Jacobsen, Meryam Sugulle, et al.. (2021). Circulating HLA-G and its association with cardiovascular markers in pregnancy. Journal of Reproductive Immunology. 146. 103331–103331. 1 indexed citations
9.
Godang, Kristin, Tove Lekva, Nicoleta Cristina Olarescu, et al.. (2019). Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study. JBMR Plus. 3(12). e10240–e10240. 8 indexed citations
10.
Lekva, Tove, Annika E. Michelsen, Pål Aukrust, et al.. (2017). Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus. Cardiovascular Diabetology. 16(1). 5–5. 54 indexed citations
11.
Norum, Hilde M., Kaspar Broch, Annika E. Michelsen, et al.. (2017). The Notch Ligands DLL1 and Periostin Are Associated with Symptom Severity and Diastolic Function in Dilated Cardiomyopathy. Journal of Cardiovascular Translational Research. 10(4). 401–410. 19 indexed citations
12.
Sundaram, Arvind Y. M., Tove Lekva, Ivars Silamiķelis, et al.. (2017). Gene expression profiling of fast- and slow-growing non-functioning gonadotroph pituitary adenomas. European Journal of Endocrinology. 178(3). 295–307. 24 indexed citations
13.
Abraityte, Aurelija, Leif Erik Vinge, Erik T. Askevold, et al.. (2017). Wnt5a is elevated in heart failure and affects cardiac fibroblast function. Journal of Molecular Medicine. 95(7). 767–777. 57 indexed citations
14.
Lekva, Tove, Errol R. Norwitz, Pål Aukrust, & Thor Ueland. (2016). Impact of Systemic Inflammation on the Progression of Gestational Diabetes Mellitus. Current Diabetes Reports. 16(4). 26–26. 112 indexed citations
15.
Lekva, Tove, Jens Bollerslev, Errol R. Norwitz, et al.. (2015). Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus. PLoS ONE. 10(8). e0136892–e0136892. 41 indexed citations
16.
Lekva, Tove, Jens Bollerslev, Kristin Godang, et al.. (2015). β-cell dysfunction in women with previous gestational diabetes is associated with visceral adipose tissue distribution. European Journal of Endocrinology. 173(1). 63–70. 35 indexed citations
17.
Ueland, Thor, Nicoleta Cristina Olarescu, Anders Palmstrøm Jørgensen, et al.. (2014). Increased Serum and Bone Matrix Levels of the Secreted Wnt Antagonist DKK-1 in Patients With Growth Hormone Deficiency in Response to Growth Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism. 100(2). 736–743. 18 indexed citations
18.
Lekva, Tove, Giovanni Davı̀, Kari Otterdal, et al.. (2012). A Complex Interaction between Rickettsia conorii and Dickkopf-1 – Potential Role in Immune Evasion Mechanisms in Endothelial Cells. PLoS ONE. 7(9). e43638–e43638. 14 indexed citations
19.
Godang, Kristin, Kathrine Frey Frøslie, Tore Henriksen, et al.. (2012). Umbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates. European Journal of Endocrinology. 168(3). 371–378. 22 indexed citations
20.
Fougner, Stine Lyngvi, Tove Lekva, Olivera Casar‐Borota, et al.. (2010). The Expression of E-Cadherin in Somatotroph Pituitary Adenomas Is Related to Tumor Size, Invasiveness, and Somatostatin Analog Response. The Journal of Clinical Endocrinology & Metabolism. 95(5). 2334–2342. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Beltrand Breakdown of academic impact, for papers by Walter Krugluger Breakdown of academic impact, for papers by Valorie L. Chiasson Breakdown of academic impact, for papers by Paolo Mannella Breakdown of academic impact, for papers by Kambiz Zandi‐Nejad Breakdown of academic impact, for papers by Sirkka-Liisa Karonen Breakdown of academic impact, for papers by Erik Van Herck Breakdown of academic impact, for papers by Kálmán Kovács Breakdown of academic impact, for papers by Kathleen Laborde Breakdown of academic impact, for papers by Ernst Beinder
Rankless by CCL
2026